Cambridge, United States
Portal Instruments is a pioneering player in the healthcare realm, explicitly focused on revolutionizing drug delivery systems. Established in 2012 and headquartered in the United States, this Series C funded company is boldly venturing into the sphere of medical devices with a core objective to enhance patient experience, particularly for those managing chronic diseases.
At the crux of Portal Instruments' innovation is a needle-free drug delivery platform drawn from MIT research. The technology stands out by utilizing pressure to deliver medications, thereby omitting the discomfort and anxiety associated with traditional needles. This platform showcases potential to set a benchmark in interactivity by offering real-time monitoring, fostering better adherence and improving patient outcomes.
While their platform remains under development and not commercially available, Portal Instruments remains promising with a recent $7.00M investment secured in April 2022. Investors eyeing novel solutions in the healthcare sector might find Portal Instruments as a valuable portfolio addition given its innovative thrust and strategic backing.
